You have 5 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recurrent Brain metastases

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-squamous NSCLC Trial in Guangzhou (FSRT combined with Bevacizumab)

Active, not recruiting
  • Non-squamous Non-small Cell Lung Cancer
  • FSRT combined with Bevacizumab
  • Guangzhou, China
    Sun Yat-sen University
Nov 25, 2022

NSCLC, EGFR Activating Mutation, Brain Metastases Trial in Beijing (TY-9591, Osimertinib)

Not yet recruiting
  • NSCLC
  • +2 more
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospitial,Chinese Academy of Medic
Jul 9, 2023

Brain Tumor, Brain Metastases, Brain Cancer Trial in Indianapolis, Portland (Reduced Dose SRS)

Recruiting
  • Brain Tumor
  • +2 more
  • Reduced Dose SRS
  • Indianapolis, Indiana
  • +2 more
Aug 29, 2022

NSCLC Trial in Pittsburgh (Tiragolumab, Atezolizumab, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 16, 2023

Brain Metastases Trial (biological samples (blood test and lumbar puncture))

Not yet recruiting
  • Brain Metastases
  • biological samples (blood test and lumbar puncture)
  • (no location specified)
May 4, 2023

Brain Metastases, Brain Metastases, Adult, Brain Cancer Trial in Miami (18F fluciclovine)

Not yet recruiting
  • Brain Metastases
  • +2 more
  • 18F fluciclovine
  • Miami, Florida
    Miami Cancer Institute
Sep 15, 2023

Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Shanghai (Pyrotinib Plus Capecitabine combined with brain

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Pyrotinib Plus Capecitabine combined with brain radiotherapy
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 14, 2023

Brain Metastases, Radiotherapy, EGFR Activating Mutation Trial in Guangdong (brain radiotherapy, Almonertinib)

Recruiting
  • Brain Metastases
  • +2 more
  • Guangdong, Guangzhou, China
    Sun-Yat-Sen university
Mar 13, 2023

Glioblastoma (GBM) Trial in Basel (Advanced diffusion-weighted MRI (ADW-MRI))

Recruiting
  • Glioblastoma (GBM)
  • Advanced diffusion-weighted MRI (ADW-MRI)
  • Basel, Switzerland
    University Hospital Basel
Jun 21, 2023

Brain Metastases, Adult Trial in Heidelberg (post-operative stereotactic radiosurgery (SRS), Whole brain radiotherapy (WBRT))

Completed
  • Brain Metastases, Adult
  • post-operative stereotactic radiosurgery (SRS)
  • Whole brain radiotherapy (WBRT)
  • Heidelberg, Germany
    Department of Radiotherapy, University of Heidelberg
Nov 2, 2022

Brain Metastases, Nonsmall Cell Lung Cancer Stage III Trial in Winston-Salem (MRI of the Brain, Blood draws, Quality of Life

Not yet recruiting
  • Brain Metastases
  • Nonsmall Cell Lung Cancer Stage III
  • MRI of the Brain
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Cente
Jan 19, 2023

Preclinical Brain Tumor Models

Recruiting
  • Brain Metastases
  • Diffuse Gliomas
  • Fresh tumor sampling
  • Marseille, France
    Assistance publique hopitaux de marseille
Sep 13, 2023

NSCLC Stage II, Bevacizumab, Immunotherapy Trial in Guangzhou (Serplulimab combined with bevacizumab and first-line chemo)

Not yet recruiting
  • Non-small Cell Lung Cancer Stage II
  • +3 more
  • Serplulimab combined with bevacizumab and first-line chemotherapy
  • Guangzhou, Guangdong, China
    Likun Chen
Apr 10, 2023

Metastatic Breast Cancer Trial in Zhengzhou (SHR-A1811, Pyrotinib, Bevacizumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Mar 13, 2023

Brain Metastases Trial in Houston (18F-Fluciclovine (Axumin), Pet Scan)

Not yet recruiting
  • Brain Metastases
  • 18F-Fluciclovine (Axumin)
  • Pet Scan
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2023

Brain Metastases Trial in Indianapolis (Radiosurgery)

Active, not recruiting
  • Brain Metastases
  • Radiosurgery
  • Indianapolis, Indiana
  • +2 more
Jun 8, 2022

Breast Cancer Stage IV Trial in Vienna (Datopotamab deruxtecan)

Recruiting
  • Breast Cancer Stage IV
  • Datopotamab deruxtecan
  • Vienna, Austria
    AKH Universitaetsklinikum Vienna, Department f. Internal medicin
May 19, 2023

Cancer, Metastasis, Metastatic Cancer Trial in Miami (Azeliragon, Stereotactic radiosurgery, Corticosteroid)

Not yet recruiting
  • Cancer
  • +4 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Mar 16, 2023

Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab-Deruxtecan (T-DXd)
  • (no location specified)
Sep 20, 2023

Metastatic Malignant Tumor to Brain Trial in Boston (Palbociclib)

Recruiting
  • Metastatic Malignant Neoplasm to Brain
  • Boston, Massachusetts
  • +1 more
Oct 25, 2021

Brain Metastases, Adult Trial in Durham (Patritumab deruxtecan)

Not yet recruiting
  • Brain Metastases, Adult
  • Patritumab deruxtecan
  • Durham, North Carolina
    Duke University Medical Center
Jan 19, 2023

Melanoma (Skin) Trial in Houston (BMS-986213 (Relatlimab-Nivolumab FDC), Nivolumab, Relatlimab)

Not yet recruiting
  • Melanoma (Skin)
  • BMS-986213 (Relatlimab-Nivolumab FDC)
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2023

Brain Metastases Trial in New York (18F-FCH PET Scan)

Completed
  • Brain Metastases
  • 18F-FCH PET Scan
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 15, 2022

Metastatic Breast Cancer, Brain Metastases Trial in Tampa (Nivolumab, Stereotactic Radiosurgery)

Active, not recruiting
  • Metastatic Breast Cancer
  • Brain Metastases
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 17, 2022

Metastatic Melanoma Trial in New York (Lifileucel (LN-144))

Recruiting
  • Metastatic Melanoma
  • Lifileucel (LN-144)
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Jan 23, 2023